Emily Fairbairn Reduces Stake in IN8bio, Inc. to 2.2% Following Charitable Donation

On May 29, 2026, Emily Fairbairn filed Amendment No. 1 to her Schedule 13D for IN8bio, Inc. (INAB), reporting a significant decrease in beneficial ownership. The Reporting Persons, which include Emily Fairbairn, Malcolm Fairbairn, and the Malcolm and Emily Fairbairn 2010 CRUT, ceased to be beneficial owners of more than 5% of the company's common stock on May 27, 2026. This change was triggered by the CRUT transferring 724,637 shares of common stock to a 501(c)(3) charitable foundation for no consideration. Following this charitable donation, Emily Fairbairn's aggregate beneficial ownership stands at 215,431 shares, representing approximately 2.2% of the outstanding common stock. Her holdings include Series C Warrants, Pre-Funded Warrants, shares held in a Roth IRA, and exercisable stock options. Malcolm Fairbairn and the CRUT each hold approximately 2.1% of the issuer. The filing indicates that the reporting group no longer maintains a dominant stakeholder position in the Delaware-based biotechnology corporation.